Fieldpoint Private Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$70K Buy
8,408
+1,137
+16% +$15.9K 0.02% 422
2022
Q1
$166K Sell
7,271
-1
-0% -$24 0.03% 329
2021
Q4
$201K Buy
7,272
+25
+0.3% +$669 0.04% 315
2021
Q3
$202K Buy
7,247
+36
+0.5% +$1.02K 0.04% 306
2021
Q2
$195K Sell
7,211
-94
-1% -$2.85K 0.04% 307
2021
Q1
$232K Sell
7,305
-2,131
-23% -$62.5K 0.05% 267
2020
Q4
$196K Buy
+9,436
New +$176K 0.04% 286
2020
Q1
Sell
-3,467
Closed -$104K 276
2019
Q4
$104K Buy
+3,467
New +$90.1K 0.03% 333
2017
Q2
Sell
-450
Closed -$5K 161
2017
Q1
$5K Buy
+450
New +$6.19K ﹤0.01% 325

Other funds holding BHC

Fieldpoint Private Securities's BHC Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Bausch Health (BHC) stake by 16% in Q2 2022, buying an estimated $15.9K and bringing the position to 8,408 shares worth $70K. The position accounts for 0.02% of the portfolio, ranked #422.

Fieldpoint Private Securities first reported a position in BHC in Q1 2017 and has held it in 9 quarters since. The position peaked at $232K in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Fieldpoint Private Securities held 8,408 shares of Bausch Health worth $70K as of Q2 2022.
  • Fieldpoint Private Securities bought 1,137 Bausch Health shares in Q2 2022, an estimated $15.9K.
  • Bausch Health made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #422 holding.
  • Fieldpoint Private Securities first reported a position in Bausch Health in Q1 2017 and has held it in 9 quarters since.
  • Fieldpoint Private Securities's Bausch Health position peaked at $232K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.